XML 78 R8.htm IDEA: XBRL DOCUMENT v3.20.1
STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Cash flows from operating activities:      
Net loss $ (68,548) $ (27,017) $ (27,916)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation and amortization 64 59 76
Loss on retirement/sales of property and equipment     5
Accretion and amortization on investments, net (1,534) (978) 273
Change in fair value of equity investment, including foreign currency translation 196 604  
Stock-based compensation for services by non-employees 68 191 200
Stock-based compensation for employees and directors 6,079 6,368 8,144
Amortization related to 401(k) contributions 9 9 32
Amortization of right-of use-assets 712    
Changes in assets and liabilities:      
Interest and other receivables 366 (528) 39
Prepaid assets 121 (752) (56)
Deposit and other assets (964)    
Accounts payable 199 479 278
Accrued compensation and benefits 2,188 (743) 542
Amount due to Janssen Biotech, Inc. 11,659 908 (1,665)
Accrued liabilities 6,211 391 (508)
Operating lease liabilities (655)    
Net cash used in operating activities (43,829) (21,009) (20,556)
Cash flows from investing activities:      
Purchases of property and equipment (413) (16)  
Purchases of marketable securities (153,467) (188,365) (100,006)
Proceeds from maturities of marketable securities 181,280 110,663 122,976
Net cash provided by (used in) investing activities 27,400 (77,718) 22,970
Cash flows from financing activities:      
Proceeds from issuances of common stock under equity plans 204 6,951 51
Proceeds from issuances of common stock from financings 19,295 86,017 1,060
Net cash provided by financing activities 19,499 92,968 1,111
Net increase (decrease) in cash, cash equivalents and restricted cash 3,070 (5,759) 3,525
Cash, cash equivalents and restricted cash at the beginning of the period 10,844 16,603 13,078
Cash, cash equivalents and restricted cash at the end of the period $ 13,914 $ 10,844 $ 16,603